An investigation for investors in NYSEMKT:AST shares was announced over potential breaches of fiduciary duties by certain directors at Asterias Biotherapeutics.
Investors who purchased shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Asterias Biotherapeutics directors breached their fiduciary duties.
Fremont, CA based biotechnology company Asterias Biotherapeutics Inc reported that its annual Total Revenue rose from $1.22 million in 2014 to $3.58 million in 2015 and that its Net Loss increased from $10.10 million in 2014 to$15.00 million in 2015.
Shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) declined from $14.77 per share in April 2015 to as low as $2.60 per share in January 2016.
On June 28, 2016, NYSEMKT:AST shares closed at $2.50 per share.
Those who purchased NYSEMKT:AST shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com